Interleukin-22 Inhibits Bleomycin-Induced Pulmonary Fibrosis
Pulmonary fibrosis is a progressive and fatal fibrotic disease of the lungs with unclear etiology. Recent insight has suggested that early injury/inflammation of alveolar epithelial cells could lead to dysregulation of tissue repair driven by multiple cytokines. Although dysregulation of interleuki...
Saved in:
| Main Authors: | Minrui Liang, Jiucun Wang, Haiyan Chu, Xiaoxia Zhu, Hang He, Qiong Liu, Jianhua Qiu, Xiaodong Zhou, Ming Guan, Yu Xue, Xiangjun Chen, Hejian Zou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2013/209179 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis
by: Kangchen Li, et al.
Published: (2025-01-01) -
Dehydrocorydaline attenuates bleomycin-induced pulmonary fibrosis by inhibiting fibroblast activation
by: Jianhan He, et al.
Published: (2025-04-01) -
Pirfenidone combined with UC-MSCs reversed bleomycin-induced pulmonary fibrosis
by: Jingran Xu, et al.
Published: (2025-08-01) -
Antrodia cinnamomea extract alleviates bleomycin-induced pulmonary fibrosis in mice by inhibiting the mTOR pathway
by: Ying-Wei Lan, et al.
Published: (2024-12-01) -
Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis
by: Fenghua Zhang, et al.
Published: (2020-06-01)